— Know what they know.
Not Investment Advice
Also trades as: 0IGA.L (LSE) · $vol 0M

EBS NYSE

Emergent BioSolutions Inc.
1W: +1.9% 1M: +1.0% 3M: -23.4% YTD: -33.1% 1Y: +20.6% 3Y: -5.6% 5Y: -86.5%
$8.45
+0.08 (+0.96%)
 
Weekly Expected Move ±7.6%
$7 $7 $8 $9 $9
NYSE · Healthcare · Biotechnology · Alpha Radar Neutral · Power 48 · $436.0M mcap · 49M float · 1.83% daily turnover · Short 60% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
38.6 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -19.9%  ·  5Y Avg: -17.4%
Cost Advantage ★
58
Intangibles
40
Switching Cost
41
Network Effect
23
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. EBS has No discernible competitive edge (38.6/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. Negative ROIC of -19.9% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$12
Avg Target
$12
High
Based on 1 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 11Hold: 3Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$12.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-03-09 H.C. Wainwright Initiated $12 +43.7% $8.35
2022-05-04 Wells Fargo Initiated $38 +14.9% $33.06
2022-04-29 Chardan Capital Initiated $65 +91.3% $33.98

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. EBS receives an overall rating of C-. Strongest factors: P/B (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-04 D+ C-
2026-05-01 B D+
2026-03-02 B+ B
2026-02-24 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

33 Grade D
Profitability
21
Balance Sheet
56
Earnings Quality
47
Growth
48
Value
41
Momentum
50
Safety
30
Cash Flow
64
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. EBS scores highest in Cash Flow (64/100) and lowest in Profitability (21/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.35
Distress Zone
Piotroski F-Score
5/9
Beneish M-Score
-3.48
Unlikely Manipulator
Ohlson O-Score
-7.28
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BB+
Score: 47.4/100
Trend: Improving
Earnings Quality
OCF/NI: -17.21x
Accruals: -11.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. EBS scores 1.35, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. EBS scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. EBS's score of -3.48 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. EBS's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. EBS receives an estimated rating of BB+ (score: 47.4/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-50.99x
PEG
0.43x
P/S
0.64x
P/B
0.84x
P/FCF
3.46x
P/OCF
3.17x
EV/EBITDA
5.18x
EV/Revenue
1.23x
EV/EBIT
12.44x
EV/FCF
6.17x
Earnings Yield
-1.83%
FCF Yield
28.87%
Shareholder Yield
7.23%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. EBS currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
-2.457
NI / EBT
×
Interest Burden
0.052
EBT / EBIT
×
EBIT Margin
0.099
EBIT / Rev
×
Asset Turnover
0.500
Rev / Assets
×
Equity Multiplier
2.694
Assets / Equity
=
ROE
-1.7%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. EBS's ROE of -1.7% is driven by Asset Turnover (0.500), indicating efficient use of assets to generate revenue. A tax burden ratio of -2.46 suggests the company retains less than 60% of pre-tax earnings after taxes.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$8.46
Median 1Y
$4.50
5th Pctile
$1.02
95th Pctile
$19.73
Ann. Volatility
88.1%
Analyst Target
$12.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Joseph Papa President,
Chief Executive Officer and Director
$1,037,385 $1,638,500 $5,321,147
Richard Lindahl President,
Vice President, Chief Financial Officer
$662,020 $851,950 $2,708,723
Coleen Glessner President,
Vice President, Quality and Ethics and Compliance
$623,551 $362,500 $1,664,258
Simon Lowry Medical
edical Officer and Head of Research and Development
$545,002 $362,500 $1,471,276
Paul Williams President,
e President, Products Business
$495,019 $362,500 $1,391,158

CEO Pay Ratio

26:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $5,321,147
Avg Employee Cost (SGA/emp): $206,778
Employees: 900

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
900
0.0% YoY
Revenue / Employee
$825,444
Rev: $742,900,000
Profit / Employee
$58,444
NI: $52,600,000
SGA / Employee
$206,778
Avg labor cost proxy
R&D / Employee
$59,111
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 23.6% 17.9% 15.1% 10.3% 6.5% 2.9% -14.1% -26.3% -40.1% -51.9% -74.7% -55.5% -57.6% -20.5% -33.7% -23.2% 24.6% 13.4% 10.5% -1.7% -1.71%
ROA 11.5% 8.7% 7.9% 5.4% 3.4% 1.5% -6.9% -12.9% -19.7% -25.4% -30.5% -22.7% -23.5% -8.4% -11.9% -8.2% 8.7% 4.7% 3.9% -0.6% -0.64%
ROIC 18.4% 14.4% 13.6% 9.7% 6.8% 3.5% -6.2% -11.8% -19.7% -26.8% -41.1% -30.5% -25.4% -8.1% -8.1% -7.4% 7.4% 8.0% 8.0% -19.9% -19.89%
ROCE 18.4% 13.4% 15.4% 11.9% 8.4% 8.0% -5.6% -13.1% -8.4% -6.3% -14.3% 0.9% -14.1% -7.6% -4.2% -3.3% 9.7% 9.7% 9.0% 5.7% 5.66%
Gross Margin 30.4% 19.1% 59.1% 34.4% 7.9% 21.3% 34.6% -14.8% 36.5% 34.2% 61.2% 46.9% -25.7% 55.9% 70.1% 53.7% 43.1% 60.3% 31.3% 43.3% 43.31%
Operating Margin 3.6% -10.5% 38.4% 2.1% -31.6% -18.9% -16.7% -89.8% -86.7% -89.5% -15.8% 13.2% -79.9% 22.0% -4.9% 22.5% 1.1% 33.1% -11.2% 6.7% 6.73%
Net Margin 1.2% -9.9% 26.2% -1.2% -22.4% -36.3% -20.3% -1.1% -77.4% -97.4% -17.9% 3.0% -1.1% 39.1% -16.1% 30.6% -8.5% 22.2% -36.7% 4.4% 4.36%
EBITDA Margin 11.6% -0.8% 48.0% 11.8% -18.4% -0.5% 7.5% -63.4% 14.2% 8.6% -4.9% 22.2% -51.6% 33.3% 10.8% 33.8% 16.7% 41.6% 4.6% 22.2% 22.17%
FCF Margin 7.1% 1.4% 5.4% 4.4% 7.9% 4.2% -15.4% -30.9% -35.5% -21.0% -24.6% -11.2% 3.4% 12.3% 3.4% 9.8% 18.2% 0.2% 21.1% 20.0% 20.01%
OCF Margin 19.1% 14.4% 17.9% 15.9% 18.3% 13.4% -3.1% -18.6% -26.1% -13.2% -19.7% -7.2% 7.0% 15.2% 5.6% 11.4% 19.8% 1.6% 23.0% 21.9% 21.87%
ROE 3Y Avg snapshot only -38.66%
ROE 5Y Avg snapshot only -26.92%
ROA 3Y Avg snapshot only -13.71%
ROIC 3Y Avg snapshot only 38.55%
ROIC Economic snapshot only -16.36%
Cash ROA snapshot only 11.22%
Cash ROIC snapshot only 16.64%
CROIC snapshot only 15.23%
NOPAT Margin snapshot only -26.14%
Pretax Margin snapshot only 0.52%
R&D / Revenue snapshot only 7.18%
SGA / Revenue snapshot only 26.68%
SBC / Revenue snapshot only 2.17%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 11.37 11.84 10.07 13.22 15.66 23.43 -2.79 -1.32 -0.62 -0.23 -0.16 -0.23 -0.61 -2.22 -2.72 -2.12 2.48 6.57 12.31 -54.53 -50.995
P/S Ratio 1.99 1.63 1.30 1.18 0.97 0.69 0.53 0.53 0.35 0.16 0.12 0.11 0.33 0.41 0.50 0.29 0.41 0.63 0.87 0.69 0.644
P/B Ratio 2.35 1.86 1.44 1.29 0.96 0.65 0.42 0.37 0.27 0.13 0.19 0.20 0.55 0.72 1.07 0.58 0.72 1.03 1.24 0.90 0.838
P/FCF 28.13 117.41 24.20 26.83 12.26 16.57 -3.43 -1.73 -0.98 -0.76 -0.48 -1.00 9.54 3.36 14.47 2.95 2.23 355.95 4.13 3.46 3.463
P/OCF 10.44 11.34 7.24 7.47 5.30 5.18 4.66 2.72 8.83 2.53 2.05 38.33 3.80 3.17 3.169
EV/EBITDA 6.45 6.59 5.09 5.56 5.48 3.97 87.46 -10.45 -35.37 -117.06 -18.86 7.07 -20.17 62.19 20.27 13.70 4.24 4.98 5.03 5.18 5.184
EV/Revenue 2.17 1.81 1.46 1.35 1.15 0.89 1.23 1.34 1.08 0.87 0.83 0.74 1.00 1.08 1.05 0.89 1.08 1.36 1.37 1.23 1.235
EV/EBIT 8.05 8.91 6.61 7.74 8.47 6.48 -12.56 -5.14 -7.08 -7.86 -5.22 88.06 -6.71 -13.55 -21.22 -20.86 7.78 9.00 9.47 12.44 12.435
EV/FCF 30.63 130.59 27.27 30.62 14.59 21.24 -8.00 -4.33 -3.04 -4.15 -3.39 -6.66 29.45 8.78 30.58 9.06 5.95 767.81 6.47 6.17 6.172
Earnings Yield 8.8% 8.4% 9.9% 7.6% 6.4% 4.3% -35.9% -75.8% -1.6% -4.4% -6.1% -4.3% -1.6% -45.0% -36.8% -47.3% 40.3% 15.2% 8.1% -1.8% -1.83%
FCF Yield 3.6% 0.9% 4.1% 3.7% 8.2% 6.0% -29.1% -57.9% -1.0% -1.3% -2.1% -1.0% 10.5% 29.7% 6.9% 33.9% 44.8% 0.3% 24.2% 28.9% 28.87%
PEG Ratio snapshot only 0.426
Price/Tangible Book snapshot only 5.447
EV/OCF snapshot only 5.646
EV/Gross Profit snapshot only 2.659
Acquirers Multiple snapshot only 11.606
Shareholder Yield snapshot only 7.23%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 3.11 3.11 3.40 3.40 3.40 3.40 0.98 0.98 0.98 0.98 1.04 1.04 1.04 1.04 3.69 3.69 3.69 3.69 5.01 5.01 5.011
Quick Ratio 2.31 2.31 2.47 2.47 2.47 2.47 0.70 0.70 0.70 0.70 0.54 0.54 0.54 0.54 1.77 1.77 1.77 1.77 2.41 2.41 2.414
Debt/Equity 0.64 0.64 0.54 0.54 0.54 0.54 1.03 1.03 1.03 1.03 1.32 1.32 1.32 1.32 1.40 1.40 1.40 1.40 1.09 1.09 1.095
Net Debt/Equity 0.21 0.21 0.18 0.18 0.18 0.18 0.56 0.56 0.56 0.56 1.15 1.15 1.15 1.15 1.19 1.19 1.19 1.19 0.70 0.70 0.702
Debt/Assets 0.32 0.32 0.29 0.29 0.29 0.29 0.45 0.45 0.45 0.45 0.47 0.47 0.47 0.47 0.49 0.49 0.49 0.49 0.43 0.43 0.434
Debt/EBITDA 1.61 2.03 1.69 2.04 2.58 2.57 90.85 -11.43 -43.62 -173.95 -18.58 6.90 -15.67 44.11 12.52 10.83 3.11 3.13 2.83 3.55 3.549
Net Debt/EBITDA 0.53 0.66 0.57 0.69 0.87 0.87 49.92 -6.28 -23.97 -95.59 -16.17 6.01 -13.63 38.38 10.68 9.24 2.65 2.67 1.82 2.27 2.275
Interest Coverage 13.77 9.82 11.50 8.98 6.53 6.18 -2.93 -5.40 -2.41 -1.55 -1.89 0.11 -1.84 -1.14 -0.73 -0.67 2.26 2.01 1.81 1.21 1.209
Equity Multiplier 1.99 1.99 1.84 1.84 1.84 1.84 2.28 2.28 2.28 2.28 2.81 2.81 2.81 2.81 2.88 2.88 2.88 2.88 2.52 2.52 2.523
Cash Ratio snapshot only 1.554
Debt Service Coverage snapshot only 2.899
Cash to Debt snapshot only 0.359
FCF to Debt snapshot only 0.237
Defensive Interval snapshot only 436.3 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.66 0.63 0.61 0.60 0.55 0.52 0.36 0.32 0.35 0.36 0.42 0.48 0.44 0.45 0.65 0.60 0.53 0.49 0.55 0.50 0.500
Inventory Turnover 3.25 3.48 3.04 3.19 3.02 2.78 2.38 2.34 2.32 2.29 2.03 1.94 2.25 2.11 2.08 1.91 1.16 1.04 1.15 1.11 1.107
Receivables Turnover 6.81 6.59 7.03 6.89 6.28 5.93 5.10 4.45 4.90 5.03 7.02 7.93 7.38 7.53 7.59 7.02 6.19 5.74 6.77 6.16 6.164
Payables Turnover 7.44 7.98 7.47 7.85 7.43 6.85 7.12 7.01 6.95 6.86 6.38 6.12 7.10 6.65 7.71 7.06 4.28 3.85 6.47 6.22 6.223
DSO 54 55 52 53 58 62 72 82 75 72 52 46 49 48 48 52 59 64 54 59 59.2 days
DIO 112 105 120 114 121 131 153 156 157 159 180 188 162 173 175 191 315 351 317 330 329.8 days
DPO 49 46 49 46 49 53 51 52 53 53 57 60 51 55 47 52 85 95 56 59 58.7 days
Cash Conversion Cycle 117 115 123 121 130 139 174 186 179 178 175 174 160 167 176 192 289 320 315 330 330.4 days
Fixed Asset Turnover snapshot only 3.295
Operating Cycle snapshot only 389.0 days
Cash Velocity snapshot only 3.295
Capital Intensity snapshot only 1.948
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 38.3% 26.3% 15.3% 3.0% -6.4% -8.6% -37.7% -44.6% -33.0% -27.0% -6.1% 21.7% 2.8% 2.0% -0.5% -18.6% -22.7% -29.9% -28.8% -29.9% -29.89%
Net Income 75.7% 36.3% -24.3% -59.3% -66.9% -80.3% -1.9% -3.5% -7.1% -18.4% -2.6% -43.4% 2.4% 73.2% 74.9% 76.7% 1.2% 1.4% 1.3% 93.5% 93.47%
EPS 74.1% 37.8% -23.0% -56.3% -64.2% -78.8% -2.0% -3.5% -7.0% -17.8% -2.5% -37.9% 6.0% 75.0% 76.0% 78.8% 1.2% 1.4% 1.3% 93.4% 93.37%
FCF -37.7% -91.6% -75.7% -75.0% 4.7% 1.8% -2.8% -4.9% -4.0% -4.7% -50.2% 56.1% 1.1% 1.6% 1.1% 1.7% 3.1% -99.0% 3.4% 43.4% 43.43%
EBITDA 52.8% 14.5% -10.3% -37.3% -41.3% -25.4% -97.0% -1.3% -1.1% -1.0% -3.9% 2.0% -67.9% 3.4% 2.2% -49.9% 5.0% 10.1% 2.7% 1.6% 1.58%
Op. Income 63.4% 31.5% -18.7% -51.3% -59.6% -51.2% -1.5% -2.2% -4.1% -5.5% -3.3% -66.4% 16.9% 80.6% 85.0% 81.7% 1.2% 1.8% 2.0% 1.7% 1.73%
OCF Growth snapshot only 34.42%
Asset Growth snapshot only -5.12%
Equity Growth snapshot only 8.24%
Debt Growth snapshot only -15.38%
Shares Change snapshot only -1.40%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 35.9% 32.8% 31.8% 27.1% 22.1% 14.1% 1.1% -3.5% -4.6% -5.5% -12.3% -11.4% -13.6% -12.0% -16.5% -18.1% -19.0% -19.5% -12.7% -11.4% -11.44%
Revenue 5Y 27.2% 27.2% 29.7% 28.4% 25.6% 23.8% 14.8% 11.6% 9.5% 9.3% 6.0% 6.8% 4.7% 2.1% -0.7% -2.3% -7.2% -9.6% -13.7% -16.9% -16.88%
EPS 3Y 36.0% 29.6% 52.0% 56.5% 1.2% 9.1% 14.5%
EPS 5Y 28.6% 34.4% 32.8% 21.5% 6.1% -12.1% -4.2% -15.2% -29.1%
Net Income 3Y 38.5% 31.4% 54.5% 56.0% 1.2% 12.1% 19.3%
Net Income 5Y 36.4% 36.6% 34.9% 22.0% 6.1% -12.3% -3.9% -14.5% -29.6%
EBITDA 3Y 39.2% 34.1% 47.8% 40.0% 51.4% 28.1% -58.9% -43.2% -65.0% -52.8% -47.3% -13.6% -13.9% 1.3%
EBITDA 5Y 24.3% 21.4% 27.3% 23.5% 16.0% 14.8% -38.2% -4.3% -34.4% -24.9% -23.8% -10.4% -11.4% -18.9% -25.1% -25.05%
Gross Profit 3Y 36.1% 31.5% 35.9% 28.4% 26.1% 15.7% -15.7% -31.8% -25.7% -23.2% -24.2% -17.8% -26.5% -17.6% -22.4% -20.9% -7.9% -8.9% 8.1% 25.2% 25.21%
Gross Profit 5Y 24.3% 21.7% 26.3% 23.8% 19.4% 18.3% 0.4% -9.8% -4.7% -1.0% 2.4% 9.2% 1.9% 0.9% -5.0% -6.9% -5.7% -7.5% -15.0% -19.8% -19.77%
Op. Income 3Y 39.5% 36.3% 57.8% 54.1% 50.5% -15.0% -10.0%
Op. Income 5Y 23.8% 22.7% 27.3% 21.6% 9.5% 5.9% -16.5% -14.1% -23.8% -33.2% -33.19%
FCF 3Y 8.1% -53.2% 5.7% -32.2% 82.0% -28.0% 6.8% 7.0% -71.9%
FCF 5Y 8.8% 22.0% 1.9% -18.7% 13.0% -4.4% -65.1% -16.9% -15.3% -15.29%
OCF 3Y 30.6% -6.1% 97.3% 23.6% 55.9% -38.2% -10.4% -43.2% -26.6% -16.7% -59.9%
OCF 5Y 17.8% 29.3% 43.1% 37.2% 20.9% 11.0% -0.1% -20.8% -4.8% -11.1% -49.9% -20.5% -21.1% -21.08%
Assets 3Y 39.1% 39.1% 9.9% 9.9% 9.9% 9.9% 10.8% 10.8% 10.8% 10.8% -14.2% -14.2% -14.2% -14.2% -22.3% -22.3% -22.3% -22.3% -25.3% -25.3% -25.32%
Assets 5Y 22.5% 22.5% 25.0% 25.0% 25.0% 25.0% 24.2% 24.2% 24.2% 24.2% -3.9% -3.9% -3.9% -3.9% -9.8% -9.8% -9.8% -9.8% -14.5% -14.5% -14.48%
Equity 3Y 16.6% 16.6% 16.8% 16.8% 16.8% 16.8% 8.4% 8.4% 8.4% 8.4% -23.4% -23.4% -23.4% -23.4% -33.1% -33.1% -33.1% -33.1% -27.8% -27.8% -27.79%
Book Value 3Y 14.5% 15.0% 14.9% 17.2% 18.0% 18.7% 10.4% 9.7% 10.4% 10.1% -22.2% -22.3% -22.8% -24.3% -33.4% -35.8% -34.9% -35.8% -29.0% -30.6% -30.58%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.88 0.94 0.95 0.93 0.92 0.91 0.46 0.30 0.29 0.29 0.03 0.01 0.01 0.00 0.08 0.08 0.39 0.58 0.92 0.82 0.821
Earnings Stability 0.43 0.48 0.58 0.36 0.19 0.05 0.05 0.12 0.27 0.37 0.47 0.48 0.53 0.35 0.45 0.44 0.22 0.14 0.18 0.21 0.211
Margin Stability 0.84 0.86 0.89 0.86 0.83 0.87 0.76 0.64 0.73 0.79 0.74 0.64 0.74 0.84 0.79 0.67 0.66 0.72 0.72 0.63 0.631
Rev. Growth Consistency 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0
Earnings Persistence 0.50 0.85 0.90 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.20 0.20 0.20 0.50 0.500
Earnings Smoothness 0.45 0.69 0.72 0.16 0.00 0.00
ROE Trend 0.14 0.08 0.01 -0.07 -0.12 -0.13 -0.33 -0.47 -0.57 -0.65 -1.17 -0.78 -0.72 -0.06 0.27 0.30 0.96 0.60 0.88 0.56 0.555
Gross Margin Trend 0.06 -0.01 -0.04 -0.10 -0.12 -0.08 -0.23 -0.32 -0.19 -0.14 -0.01 0.16 -0.01 0.02 0.06 0.06 0.29 0.26 0.14 0.06 0.059
FCF Margin Trend -0.00 -0.01 -0.12 -0.07 -0.03 -0.07 -0.31 -0.42 -0.43 -0.24 -0.20 0.02 0.17 0.21 0.23 0.31 0.34 0.05 0.32 0.21 0.207
Sustainable Growth Rate 23.6% 17.9% 15.1% 10.3% 6.5% 2.9% 24.6% 13.4% 10.5%
Internal Growth Rate 13.0% 9.5% 8.6% 5.7% 3.5% 1.6% 9.5% 5.0% 4.0%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.09 1.04 1.39 1.77 2.95 4.52 0.16 0.46 0.46 0.19 0.27 0.15 -0.13 -0.82 -0.31 -0.84 1.21 0.17 3.24 -17.21 -17.209
FCF/OCF 0.37 0.10 0.30 0.28 0.43 0.31 5.04 1.67 1.36 1.59 1.25 1.56 0.49 0.81 0.61 0.86 0.92 0.11 0.92 0.91 0.915
FCF/Net Income snapshot only -15.744
OCF/EBITDA snapshot only 0.918
CapEx/Revenue 12.0% 13.0% 12.6% 11.4% 10.4% 9.2% 12.3% 12.4% 9.4% 7.8% 4.9% 4.0% 3.6% 2.9% 2.2% 1.6% 1.6% 1.5% 1.9% 1.9% 1.86%
CapEx/Depreciation snapshot only 0.134
Accruals Ratio -0.01 -0.00 -0.03 -0.04 -0.07 -0.05 -0.06 -0.07 -0.11 -0.21 -0.22 -0.19 -0.27 -0.15 -0.16 -0.15 -0.02 0.04 -0.09 -0.12 -0.116
Sloan Accruals snapshot only 0.000
Cash Flow Adequacy snapshot only 11.746
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 0.0% 46.0% 1.0% 1.9% 4.2% 4.9% 20.8% 47.3%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 4.6% 7.9% 12.1% 18.0% 13.9% 4.7% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.0% 3.2% 3.8% 7.2% 7.23%
Net Buyback Yield 0.0% 0.0% 4.4% 7.7% 11.9% 17.6% 13.9% 4.7% -2.5% -5.3% -7.8% -7.3% -0.3% -2.2% -2.1% -3.9% -1.1% 2.8% 3.5% 6.7% 6.70%
Total Shareholder Return 0.0% 0.0% 4.4% 7.7% 11.9% 17.6% 13.9% 4.7% -2.5% -5.3% -7.8% -7.3% -0.3% -2.2% -2.1% -3.9% -1.1% 2.8% 3.5% 6.7% 6.70%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.75 0.76 0.73 0.70 0.75 0.41 0.97 1.05 1.12 1.05 1.04 1.01 1.02 1.23 1.33 2.11 0.73 0.72 0.64 -2.46 -2.457
Interest Burden (EBT/EBIT) 0.87 0.89 0.79 0.73 0.60 0.53 2.00 1.48 3.30 6.04 4.37 -55.85 3.50 1.90 2.77 1.52 1.61 0.89 0.77 0.05 0.052
EBIT Margin 0.27 0.20 0.22 0.17 0.14 0.14 -0.10 -0.26 -0.15 -0.11 -0.16 0.01 -0.15 -0.08 -0.05 -0.04 0.14 0.15 0.14 0.10 0.099
Asset Turnover 0.66 0.63 0.61 0.60 0.55 0.52 0.36 0.32 0.35 0.36 0.42 0.48 0.44 0.45 0.65 0.60 0.53 0.49 0.55 0.50 0.500
Equity Multiplier 2.06 2.06 1.91 1.91 1.91 1.91 2.04 2.04 2.04 2.04 2.45 2.45 2.45 2.45 2.84 2.84 2.84 2.84 2.69 2.69 2.694
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $5.54 $4.23 $4.32 $3.11 $1.98 $0.90 $-4.24 $-7.85 $-11.87 $-15.02 $-14.65 $-10.83 $-11.16 $-3.76 $-3.52 $-2.30 $2.57 $1.34 $1.00 $-0.15 $-0.15
Book Value/Share $26.80 $26.95 $30.12 $31.79 $32.23 $32.29 $27.81 $27.64 $27.37 $26.79 $12.51 $12.44 $12.34 $11.68 $8.91 $8.43 $8.91 $8.55 $9.97 $9.25 $10.08
Tangible Book/Share $9.58 $9.63 $14.62 $15.42 $15.64 $15.67 $8.83 $8.78 $8.69 $8.51 $1.59 $1.58 $1.57 $1.49 $-0.35 $-0.33 $-0.35 $-0.33 $1.64 $1.52 $1.52
Revenue/Share $31.64 $30.77 $33.51 $34.66 $31.99 $30.27 $22.39 $19.41 $21.15 $21.29 $20.22 $22.71 $20.95 $20.24 $19.25 $16.85 $15.71 $13.96 $14.18 $11.98 $13.04
FCF/Share $2.24 $0.43 $1.80 $1.53 $2.53 $1.27 $-3.44 $-6.00 $-7.50 $-4.46 $-4.97 $-2.53 $0.71 $2.48 $0.66 $1.65 $2.86 $0.02 $2.99 $2.40 $2.61
OCF/Share $6.03 $4.42 $6.00 $5.50 $5.86 $4.05 $-0.68 $-3.60 $-5.51 $-2.81 $-3.97 $-1.63 $1.46 $3.07 $1.08 $1.92 $3.12 $0.23 $3.26 $2.62 $2.85
Cash/Share $11.51 $11.57 $10.77 $11.37 $11.53 $11.55 $12.88 $12.80 $12.67 $12.41 $2.15 $2.14 $2.12 $2.01 $1.84 $1.74 $1.84 $1.76 $3.92 $3.64 $3.09
EBITDA/Share $10.63 $8.45 $9.62 $8.43 $6.74 $6.78 $0.31 $-2.49 $-0.64 $-0.16 $-0.89 $2.39 $-1.04 $0.35 $1.00 $1.09 $4.01 $3.82 $3.85 $2.85 $2.85
Debt/Share $17.09 $17.19 $16.28 $17.18 $17.42 $17.45 $28.59 $28.41 $28.13 $27.54 $16.57 $16.48 $16.35 $15.47 $12.47 $11.80 $12.47 $11.97 $10.92 $10.13 $10.13
Net Debt/Share $5.59 $5.62 $5.51 $5.81 $5.89 $5.91 $15.71 $15.61 $15.46 $15.13 $14.42 $14.34 $14.23 $13.46 $10.64 $10.06 $10.64 $10.21 $7.00 $6.49 $6.49
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 1.348
Altman Z-Prime snapshot only 3.204
Piotroski F-Score 6 7 7 7 6 7 3 3 3 3 4 4 4 6 6 5 6 5 6 5 5
Beneish M-Score -2.31 -1.95 -2.46 -2.20 -0.86 -2.55 -2.72 -4.99 -3.41 -3.82 -4.08 -4.07 -5.34 -3.64 -3.64 -3.62 -3.54 -2.55 -2.79 -3.48 -3.478
Ohlson O-Score snapshot only -7.284
ROIC (Greenblatt) snapshot only 9.13%
Net-Net WC snapshot only $-2.36
EVA snapshot only $-265844285.71
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB+
Credit Score 82.70 71.42 79.05 74.53 69.07 68.18 14.50 21.48 21.29 21.56 22.94 18.06 24.36 18.78 25.08 27.27 51.17 46.82 50.56 47.42 47.418
Credit Grade snapshot only 11
Credit Trend snapshot only 20.149
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 45
Sector Credit Rank snapshot only 40

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms